Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Young plasma in Parkinson's disease
NCT02968433Phase 1Completed
- Sponsor
- Stanford University
- Start
- Nov 2016
- Primary completion
- Dec 2019
- Modality
- Recombinant Proteins and Enzymes, Tissue Cells
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of young fresh frozen plasma in Parkinson's disease (PD), sponsored by Stanford University. Primary endpoint: Number of Related and Unrelated Adverse Events at 8 weeks. Started Nov 2016; status: completed.
02
Drugs
young fresh frozen plasma
03
Conditions
Parkinson's disease (PD)
Beyond the preview
Go deeper on NCT02968433.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02968433.